Mermoud Andre

Mercieca Karl, Azzopardi Matthew, Vallabh Neeru A, Cristian Cristina, Prokosch Verena, Dubois Vincent et al.

This study compared three glaucoma surgeries, finding deep sclerectomy and canaloplasty provided better IOP control and success than viscocanalostomy, though DS needed more interventions. This suggests DS and CP are generally more effective for moderate IOP targets.

Szurman Peter, Gillmann Kevin, Seuthe Anna-Maria, Dick H Burkhard, Hoffmann Esther M, Mermoud Andre et al.

The EYEMATE-SC suprachoroidal sensor was studied for continuous IOP monitoring. It proved safe, well-tolerated, and accurately measured IOP for 12 months, offering a promising tool for glaucoma management.

Szurman Peter, Mansouri Kaweh, Dick H Burkhard, Mermoud Andre, Hoffmann Esther M, Mackert Marc et al.

A suprachoroidal IOP sensor was safe and allowed continuous monitoring in glaucoma patients, showing good agreement with Goldmann tonometry by six months, offering a new tool for long-term IOP management.

Belda Jose I, Loscos-Arenas Jordi, Mermoud Andre, Lozano Esther, D'Alessandro Elisa, Rebolleda Gema et al.

This study found that implanting the Esnoper V-2000 device for glaucoma, whether supraciliary or intrascleral, was equally safe and effective in lowering eye pressure and reducing medication.

Codreanu Andrea, Tran Hoai V, Wiaux Christophe, Mansouri Kaweh, Roy Sylvain, Mermoud Andre et al.

This rabbit study found X-shaped PMMA and collagen implants for deep sclerectomy similarly lowered IOP and increased outflow, with PMMA showing more new drainage vessels.

Ambresin Aude, Shaarawy Tarek, Mermoud Andre

This study compared deep sclerectomy with trabeculectomy, finding both effectively lowered IOP, but deep sclerectomy had fewer early complications. This suggests it's a safer alternative for glaucoma management.